Oct. 18, 2024 – Older people who aren’t sure about whether to get the vaccine for respiratory syncytial virus (RSV) now have a new set of data to help them make up their minds. A large study in The Lancet concluded the vaccine is 80% effective at preventing hospitalization due to co...
There's no approved vaccine for RSV, or respiratory syncytial virus, which can be more severe in older adults as well as in very young children. Moderna isn't the only vaccine-maker on the trail of the sought-after vaccine, however: GlaxoSmithKline, Johnson & Johnson and Pfizer all haveva...
Further, the CDC suggests in the statement that health care providers talk to their adult patients about any other vaccines they might need in the fall to help protect themselves against respiratory infections. Reference CDC. CDC recommends RSV vaccine for older adults. Published June 30, 2023. ...
(NEW YORK) — Moderna’s respiratory syncytial virus, or RSV, vaccine for older adults was about 84% effective at preventing serious illness, according to data from a late-stage trial published Tuesday. Adult patients in the clinical trial appeared to tolerate the vaccine well and there were...
If you’re an older adult, RSV can be more dangerous. If you’re 75 or older, your doctor may recommend a single dose of the RSV vaccine to prevent problems. Experts also recommend a single dose of the vaccine for adults 60 to 74 years old and up who are at high risk for severe ...
The ACIP did not hold a vote on whether to recommend RSV vaccination for patients aged 50 to 59 years despite the FDA’s recent decision to extend the approval of GSK’s vaccine for high-risk patients in that age group. References: ...
In the US, Arexvy is indicated for the prevention of RSV-LRTD in individuals 60 years of age and older. GSK’s RSV older adult vaccine is not currently approved anywhere outside the US. The proposed trade name remains subject to regulatory approval outside...
People here voluntarily opted to wear masks during a recent flu outbreak, for example. JR: What challenges do you anticipate in your region when the RSV vaccine becomes available? YL: The issue of vaccine affordability is a significant factor that could influence uptake rates of an RSV vaccine...
GSK releases strong efficacy data for older adult vaccine candidate RSV OA ahead of IDWeek2022 conference presentation.
When is the optimal time for administering RSV vaccines whether to an adult over 60 or a pregnant woman? How important is the timing of administration if this is a single-dose vaccine? If a medication error occurs, such as an adjuvant vaccine given to a pregnant woman, what steps should ...